MARKET

LENSF

LENSF

Presbia
EXMKT

Real-time Quotes | Nasdaq Last Sale

0.015
0.000
0.00%
Closed 16:00 05/17 EDT
OPEN
--
PREV CLOSE
0.020
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.190
52 WEEK LOW
0.0012
MARKET CAP
258.44K
P/E (TTM)
-0.0303
1D
5D
1M
3M
1Y
5Y
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday morning, 120 companies achieved new lows for the year.
Benzinga · 09/25/2019 15:56
No Data
Learn about the latest financial forecast of LENSF. Analyze the recent business situations of Presbia through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average LENSF stock price target is 10.00 with a high estimate of 10.00 and a low estimate of 10.00.
High10.00
Average10.00
Low10.00
Current 0.0150
EPS
Actual
Estimate
-0.14-0.11-0.07-0.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Institutional Holdings
Institutions: 1
Institutional Holdings: 86.03K
% Owned: 0.50%
Shares Outstanding: 17.23M
TypeInstitutionsShares
Increased
0
0
New
0
0
Decreased
0
0
Sold Out
11
2.78M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.75%
Healthcare Equipment & Supplies
+2.39%
Key Executives
Chairman/Director
Zohar Loshitzer
Chief Operating Officer
Casey Lind
Director
Gerd Auffarth
Director
Gerald Farrell
Director
Richard Ressler
Director
Mark Yung
No Data
No Data
About LENSF
Presbia PLC is an ophthalmic device company. The Company develops and markets an optical lens implant for treating presbyopia, the age-related loss of the ability to focus on near objects. The Company's segment is the restoration of clear vision caused by presbyopia. The Company provides the refractive lens for patient surgeries and accessories for procedures performed exclusively outside the United States. The Company's lens, referred to as the microlens, is a miniature lens designed to be surgically implanted in a patient's eye to improve that patient's ability to see objects at close distances. The microlens is a disc shaped lens that has a refractive zone in the periphery designed to improve near vision problems associated with presbyopia and a central zone that is designed to improve distance vision. The Company's solution is a standalone solution for plano presbyopes, or those individuals suffering from presbyopia but do not have any other visual disorders.

Webull offers kinds of Presbia PLC stock information, including EXMKT:LENSF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LENSF stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LENSF stock methods without spending real money on the virtual paper trading platform.